Light Mode
$23.63 ↑ +0.00 (+0.00%) Trading Up from the previous close of $23.63, $0.42 below the day’s high of $24.05
+13.03 (+122.92%) / 6M
Momentum, market sentiment, and recent alerts
FTRE reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +127.4%.
No alerts for FTRE in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
